FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Final Rule, Guidance Issue on Drug Importation

FDA and HHS announce a final rule that allows FDA-authorized programs to import certain prescription drugs from Canada if specific conditions to ensur...

Human Drugs

Novartis to Start AVXS-101 IT Confirmatory Study

Novartis Gene Therapies says it will conduct an FDA-recommended pivotal confirmatory study of its AVXS-101 intrathecal formulation in older patients w...

Human Drugs

Court Says Private Plaintiffs Cant Second-Guess FDA

Attorney James Beck says defense attorneys in FDA preemption cases would benefit from reading a recent North Carolina federal court decision that uphe...

Federal Register

Info Collection on Genetic/Genomic-Based IVDs

Federal Register notice: FDA seeks comments on an information collection extension entitled Use of Public Human Genetic Variant Databases To Support C...

Federal Register

Proposal to Clarify Medical Product Intended Use

Federal Register proposed rule: FDA proposes to amend its medical product intended use regulations to describe the types of evidence relevant to deter...

Human Drugs

FDA Denies Without Comment Taiho Lonsurf Petition

FDA denies without comment on potential future action a Taiho petition seeking restrictions on generic versions of its Lonsurf tablets.

Human Drugs

FDA Orders Benzodiazepine Boxed Warning Change

FDA says it is ordering labeling changes to benzodiazepines to highlight risks of abuse, misuse, addiction, withdrawal symptoms, etc.

Human Drugs

FDA Accepts Pfizer sNDA for Xalkori Indication

FDA grants priority review for Pfizers Xalkori sNDA to treat some pediatric lymphoma patients.

FDA General

Hahn Testifies to Reassure FDA Independence with Covid-19

FDA commissioner Stephen Hahn testifies on Capitol Hill to reassure lawmakers and the public that a transparent science- and data-based review, and no...

Federal Register

Prexxartan Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that Carmel Biosciences Prexxartan (valsartan) oral solution was not withdrawn due to safety or effectiveness ...